Klinični primer bolnika z razsejanim ploščatoceličnim karcinomom požiralnika

Show document
A+ | A- | | SLO | ENG

Title:	Klinični primer bolnika z razsejanim ploščatoceličnim karcinomom požiralnika
Authors:	ID Boc, Marko (Author) ID Mesti, Tanja (Author) ID Reberšek, Martina (Author)
Files:	PDF - Presentation file, download (350,35 KB) MD5: CF8396299DBC2ABD881268ADFA81506B
Language:	Slovenian
Typology:	1.09 - Published Professional Conference Contribution
Organization:	OI - Institute of Oncology
Keywords:	rak požiralnika, ploščatocelični rak, radiokemoterapija, rak prebavil
Publication status:	Published
Publication version:	Version of Record
Year of publishing:	2014
Number of pages:	str. 63-64, 76
Numbering:	Letn. 18, št. 1
PID:	20.500.12556/DiRROS-8833
UDC:	616.3-006
ISSN on article:	1408-1741
URN:	URN:NBN:SI:doc-BLXFYRI4
COBISS.SI-ID:	1809787
Copyright:	by Authors
Publication date in DiRROS:	31.08.2018
Views:	3539
Downloads:	983
Metadata:
:	BOC, Marko, MESTI, Tanja and REBERŠEK, Martina, 2014, Klinični primer bolnika z razsejanim ploščatoceličnim karcinomom požiralnika. In : Šola: tumorji prebavil II, Ljubljana, 15. 11. 2013 [online]. Published Professional Conference Contribution. 2014. p. 63–64, 76. [Accessed 14 April 2025]. Retrieved from: https://dirros.openscience.si/IzpisGradiva.php?lang=eng&id=8833 Copy citation

Share:

Similar works from our repository:

Similar works from other repositories:

Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Title:	Šola: tumorji prebavil II, Ljubljana, 15. 11. 2013
Publisher:	Onkološki inštitut
COBISS.SI-ID:	1807227

License:	CC BY 4.0, Creative Commons Attribution 4.0 International

Link:	http://creativecommons.org/licenses/by/4.0/
Description:	This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:	31.08.2018

Language:	English
Title:	[A clinical case of a patient with metastatic squamous cells carcinoma of the oesophagus]
Abstract:	The incidence of oesophageal cancer has not changed in the last years, neither in the world nor in Slovenia. According to the 2012 Cancer Registry of Slovenia, a total of 87 patients were diagnosed with oesophageal cancer in 2009, of which 74 were males and 13 were females. The most common histological type was squamous cell carcinoma; in 2009, there were 60 such patients, while adenocarcinoma, which is the second most common type, was found in 19 patients. Patients with oesophageal cancer have a poor prognosis. A half of these patients have advanced disease already at diagnosis. Median survival with advanced disease is eight to ten months, while 5-year survival is merely 5-17%. When the disease is operable, patients are treated surgically, and if the disease is limited locoregionally, the patients are treated with pre-operative chemoradiotherapy and surgery. However, despite such primary treatment, the disease recurs in approximately 65% of patients in the first five years, either in a form of metastases or as a local recurrence (2, 3, 4, 5, 6). In this article, we present a patient with squamous cell carcinoma of the middle third of the oesophagus which has started to spread to the upper and lower thirds six months after primary treatment and effective first-line systemic treatment.